A case of endocarditis caused by the yeast Pichia fabianii with biofilm production and developed in vitro resistance to azoles in the course of antifungal treatment

References

• Horstkotte D, Follath F, Gutschik E, et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. Eur Heart J 2004; 25: 267–276
   PubMed Web of Science ®Google Scholar
• Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005; 111: e394–434
   PubMed Web of Science ®Google Scholar
• Lopez-Ciudad V, Castro-Orjales MJ, Leon C, et al. Successful treatment of Candida parapsilosis mural endocarditis with combined caspofungin and voriconazole. BMC Infect Dis 2006; 6: 73
   PubMed Web of Science ®Google Scholar
• Rajendram R, Alp NJ, Mitchell AR, Bowler IC, Forfar JC. Candida prosthetic valve endocarditis cured by caspofungin therapy without valve replacement. Clin Infect Dis 2005; 40: e72–74
   PubMed Web of Science ®Google Scholar
• Nohinek B, Zee-Cheng CS, Barnes WG, Dall L, Gibbs HR. Infective endocarditis of a bicuspid aortic valve caused by Hansenula anomala. Am J Med 1987; 82: 165–168
   PubMed Web of Science ®Google Scholar
• Buchaille L, Freydière AM, Guinet R, Gille Y. Evaluation of six commercial systems for identification of medically important yeasts. Eur J Clin Microbiol Infect Dis 1998; 17: 479–488
   PubMed Web of Science ®Google Scholar
• Barnett JA, Payne RW, Yarrow D. Yeasts: Characteristics and Identification. 3rd ed. Cambridge: Cambridge University Press; 2000.
   Google Scholar
• Kurtzman CP Pichia E.C. Hansen emend. Kurtzman. In: Kurtzman CP, Fell JW. The Yeasts: A Taxonomic Study, 4th ed. Amsterdam: Elsevier; 1998; pp 273–352.
   Google Scholar
• Naumov GI, Naumova ES, Schnurer J. Genetic characterization of the nonconventional yeast Hansenula anomala. Res Microbiol 2001; 152: 551–562
   PubMedGoogle Scholar
• Shin JH, Kee SJ, Shin MG, et al. Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources. J Clin Microbiol 2002; 40: 1244–1248
   PubMed Web of Science ®Google Scholar
• Dooley DP, Beckius ML, McAllister CK, Jeffery BS. Prostatitis caused by Hansenula fabianii. J Infect Dis 1990; 161: 1040–1041
   PubMed Web of Science ®Google Scholar
• Bhally HS, Jain S, Shields C, et al. Infection in a neonate caused by Pichia fabianii: importance of molecular identification. Med Mycol 2006; 44: 185–187
   PubMed Web of Science ®Google Scholar
• Valenza G, Valenza R, Brederlau J, Frosch M, Kurzai O. Identification of Candida fabianii as a cause of lethal septicaemia. Mycoses 2006; 49: 331–334
   PubMed Web of Science ®Google Scholar
• Thuler LC, Faivichenco S, Velasco E, et al. Fungaemia caused by Hansenula anomala – an outbreak in a cancer hospital. Mycoses 1997; 40: 193–196
   PubMed Web of Science ®Google Scholar
• Bakir M, Cerikcioglu N, Tirtir A, et al. Pichia anomala fungaemia in immunocompromised children. Mycoses 2004; 47: 231–235
   PubMed Web of Science ®Google Scholar
• Hirasaki S, Ijichi T, Fujita N, et al. Fungemia caused by Hansenula anomala: successful treatment with fluconazole. Intern Med 1992; 31: 622–624
   PubMedGoogle Scholar
• Hall L, Wohlfiel S, Roberts GD. Experience with the MicroSeq D2 large-subunit ribosomal DNA sequencing kit for identification of commonly encountered, clinically important yeast species. J Clin Microbiol 2003; 41: 5099–5102
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved Standard-M27A2. National Committee for Clinical Laboratory Standards, Wayne, PA.
   Google Scholar
• Pfaller MA, Diekema DJ, Rex JH, et al. Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints. J Clin Microbiol 2006; 44: 819–826
   PubMed Web of Science ®Google Scholar
• Panackal AA, Gribskov JL, Staab JF, et al. Clinical significance of azole antifungal drug cross-resistance in Candida glabrata. J Clin Microbiol 2006; 44: 1740–1743
   PubMed Web of Science ®Google Scholar
• Magill SS, Shields C, Sears CL, Choti M, Merz WG. Triazole cross-resistance among Candida spp.: case report, occurrence among bloodstream isolates, and implications for antifungal therapy. J Clin Microbiol 2006; 44: 529–535
   PubMed Web of Science ®Google Scholar